Nevertheless, the skewing of peripheral CD8+ T-cell pools away from the naive subsets as demonstrated in the OSCC patients may suggest that chronic exposure to tumor-associated antigens, like p53 or enolase, tends to drive the naïve cells to effector memory and to terminally differentiated effectors. The gene discussed is TP53; the disease is neoplasm.